- Latest available (Revised)
- Original (As made)
There are currently no known outstanding effects for the The Competition Act 1998 (Concurrency) Regulations 2014, Section 8.
Revised legislation carried on this site may not be fully up to date. At the current time any known changes or effects made by subsequent legislation have been applied to the text of the legislation you are viewing by the editorial team. Please see ‘Frequently Asked Questions’ for details regarding the timescales for which new effects are identified and recorded on this site.
8.—(1) The CMA may direct a regulator M1 to transfer a case in respect of which the regulator is exercising Part 1 functions to the CMA where the CMA is satisfied that—
(a)it exercising the Part 1 functions rather than the regulator would further the promotion of competition, within any market or markets in the United Kingdom, for the benefit of consumers; F1...
F2(b). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
(2) If the CMA proposes to exercise the power in paragraph (1) the CMA must first consult the regulator who is exercising Part 1 functions in respect of the case, explaining the reasons why the CMA considers it appropriate to exercise that power.
(3) If, following the consultation referred to in paragraph (2), the CMA still proposes to exercise the power in paragraph (1), the CMA must—
(a)notify—
(i)the regulator who is exercising Part 1 functions in respect of the case,
(ii)the undertaking which is the subject of the exercise of Part 1 functions in the case (the undertaking concerned), and
(iii)any other persons likely to be materially affected by the transfer,
of what it proposes,
(b)give such recipients of the notice the opportunity to make written representations upon the proposal within no less than 10 working days of the date of that notice, and
(c)take into account any representations made in accordance with paragraph (3)(b).
(4) Once the CMA has reached a decision whether to exercise the power in paragraph (1), the CMA must—
(a)inform the recipients of the notice under paragraph (3)(a) in writing of its decision and the reasons for it; and
(b)if the CMA has decided to exercise the power in paragraph (1), inform such recipients in writing that the CMA is to exercise jurisdiction in respect of the case from the date of the transfer.
(5) The CMA is not under any obligation to notify or inform any person referred to in paragraph (3)(a)(ii) or (iii) in accordance with this regulation if the regulator has not informed that person that it has exercised Part 1 functions in respect of the case.
(6) The CMA may not exercise the power in paragraph (1) in respect of a case where a regulator has given notice under section 31(1) of the Act that it proposes to make a decision (within the meaning given by section 31(2) of the Act) in that case.
Textual Amendments
F1Word in reg. 8(1) omitted (1.7.2022) by virtue of The Health and Care Act 2022 (Consequential and Related Amendments and Transitional Provisions) Regulations 2022 (S.I. 2022/634), regs. 1(2), 115(4)(a)
F2Reg. 8(1)(b) omitted (1.7.2022) by virtue of The Health and Care Act 2022 (Consequential and Related Amendments and Transitional Provisions) Regulations 2022 (S.I. 2022/634), regs. 1(2), 115(4)(b)
Marginal Citations
M1“regulator” is defined in section 54(1) of the Competition Act 1998.
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As Enacted or Made): The original version of the legislation as it stood when it was enacted or made. No changes have been applied to the text.
Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Explanatory Memorandum sets out a brief statement of the purpose of a Statutory Instrument and provides information about its policy objective and policy implications. They aim to make the Statutory Instrument accessible to readers who are not legally qualified and accompany any Statutory Instrument or Draft Statutory Instrument laid before Parliament from June 2004 onwards.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
This timeline shows the different points in time where a change occurred. The dates will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. The first date in the timeline will usually be the earliest date when the provision came into force. In some cases the first date is 01/02/1991 (or for Northern Ireland legislation 01/01/2006). This date is our basedate. No versions before this date are available. For further information see the Editorial Practice Guide and Glossary under Help.
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: